Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Noradrenaline (Norepinephrine) 0.08 mg/ml (4 mg in 50 ml) solution for infusion in a vial with potential risk of medication errors

In June 2015 Aguettant Ltd received marketing approval for a new Noradrenaline product: namely Noradrenaline (base) 0.08 mg/ml solution for infusion (equivalent to Noradrenaline Tartrate 0.16mg/ml) presented in a 50 ml vial. This product differs from existing Noradrenaline products in both strength and presentation. There is a potential risk of medication errors should healthcare professionals not recognise these new features. Please refer to the Direct Healthcare Professional Communication for further details.

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.